Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled NO ReDuce postoperatIve pulmoNAry complicATions in patiEnts With Recent COVID-19 Infection

NCT05721144 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05721144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled NO ReDuce postoperatIve pulmoNAry complicATions in patiEnts With Recent COVID-19 Infection
Lead sponsor
Xijing Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 17, 2023
Completion date
May 7, 2024
Enrollment
660 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, nitric oxide, postoperative complications, surgery